FABRICATION AND IN VITRO EVALUATION OF NATEGLINIDE-LOADED ETHYL CELLULOSE NANOPARTICLES
Abstract
Objective: The objective of the present study is to formulate freeze-dried oral sustained release polymeric nanoparticles of nateglinide (NTG) to
decrease dosing frequency, increase bioavailability, and minimize side effects.
Methods: NTG-loaded ethyl cellulose (EC) nanoparticles were prepared by solvent evaporation technique and subjected to various studies for
characterization, such as particle size, zeta potential, drug loading (DL), entrapment efficiency (EE), scanning electron microscopy, and evaluated for
in vitro drug release.
Results: From this study, it was observed that the fabricated nanoparticles showed satisfactory results, i.e. particle size with 172 nm, 72.19% EE,
−15.81 mV zeta potential, and 14.30% DL. The results of in vitro release show that sustained release of NTG from the nanoparticles over the period
of 12 hrs and comparable with the immediate release tablets. Furthermore, accelerated stability studies revealed that the formulation is stable as per
International Conference on Harmonisation guidelines.
Conclusion: Thus, the nanoparticles formulation could be a promising delivery system for NTG with improved anti-diabetic activity, stability, and
bioavailability.
Keywords: Drug delivery, Nanoparticles, Nateglinide, In vitro release, Solvent evaporation method.
Downloads
References
Govindasamy G, Krishnamoorthy K, Rajappan M. Selection of
excipients for nanoparticles formulations of nateglinide through drugexcipients
compatibility study.
Int J Pharm PharmSci 2013;5(2):371-7.
Behera A, Sahoo SK. Development and in vitro, in vivo evaluation
of controlled release, biocompatible nanoparticles. Dig J Nanomater
Biostruct 2012;7(1):217-25.
Daisy P, Jeeva Kani FG. Evaluation of antidiabetic activity of various
extracts of cassia Auriculata Linn. Bark on streptozotocin-induced
diabetic Wistar rats. Int J Pharm PharmSci 2012;4 Suppl 4:312-8.
Dhanalekshmi UM, Poovi G, Neelakanta Reddy P. In vitro observation
of repaglinide engineered polymeric nanoparticles. Dig J Nanomater
Biostruct 2012;7(1):1-18.
Jassim JE, Hussein AA. Formulation and evaluation of clopidogrel
tablet incorporating drug nanoparticles. Int J Pharm PharmSci
;6(1):838-51.
Kaleemuddin M, Srinivas P. Lyophilized oral sustained release
polymeric nanoparticles of nateglinide. AAPS PharmSciTech
;14(1):78-85.
Jain S, Saraf S. Influence of processing variables and in vitro
characterization of glipizide loaded biodegradable nanoparticles.
Diabetes Metab Syndr Clin Res Rev 2009;3:113-7.
Dhana Lekshmi UM, Poovi G, Kishore N, Neelakanta Reddy P.
In vitro characterization and in vivo toxicity study of repaglinide
loaded poly (methyl methacrylate) nanoparticles. Int J Pharm
;396(1-2):194-203.
Kashanian S, Azandaryani AH, Derakhshandeh K. New surface-modified
solid lipid nanoparticles using N-glutaryl phosphatidylethanolamine as
the outer shell. Int J Nanomedicine 2011;6:2393-401.
Hoa LT, Chi NT, Triet NM, Nhan LN, Chien DM. Preparation of
drug nanoparticles by emulsion evaporation method. J Phys Conf Ser
;187:1-4.
Madhavi A, Reddy GS, Suryanarayana MV, Naidu A. Development of
a new analytical method for determination of related components in
nateglinide. Chromatographia 2008;67:639-45.
Tang J, Xu N, Ji H, Liu H, Wang Z, Wu L. Eudragit nanoparticles
containing genistein: Formulation, development, and bioavailability
assessment. Int J Nanomedicine 2011;6:2429-35.
Devarajan PV, Sonavane GS. Preparation and in vitro/in vivo evaluation
of gliclazide loaded eudragit nanoparticles as a sustained release
carriers. Drug Dev Ind Pharm 2007;33:101-11.
Ravikumara NR, Madhusudhan B, Nagaraj TS, Hiremat SR, Raina G.
Preparation and evaluation of nimesulide-loaded ethylcellulose and
methylcellulose nanoparticles and microparticles for oral delivery.
J Biomat Appl 2009;24(1):47-64.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.